دانلود کتاب Glaucoma Update VI

فهرست مطالب :

Front Matter....Pages I-XXIV
Definitions, Terminology, and a New Way of Staging Glaucoma....Pages 3-9
Remote Ophthalmology Care in Northern Finland....Pages 11-15
Pigment Dispersion Syndrome....Pages 17-28
Risk Factors in Pigmentary Glaucoma....Pages 29-35
The Vascular Pharmacology of Ocular Hypotensive Drugs: A New Approach to the Therapy of Visual Loss....Pages 37-41
Myocilin Mutations in Families with Late-Onset Primary Open-Angle Glaucoma....Pages 45-50
Characterization of a Large Family with Adult-Onset Primary Open-Angle Glaucoma Caused by a Mutation in the GLC1A Gene....Pages 51-55
Pitfalls in Mutation Screening for the Gene TIGR/MYOC....Pages 57-61
TIGR/MYOC Gene Mutations Found in Japanese POAG Patients....Pages 63-66
Gene Therapy of Cultured Rat Retinal Ganglion Cells....Pages 67-69
Optic Nerve Head Blood Flow Measured by Laser-Doppler Flowmetry....Pages 73-84
Change in the Optic Nerve Head Caused by Endothelin-1-Induced Chronic Ischaemia....Pages 85-88
Effects of Ifenprodil on Aqueous Dynamics and Ocular Circulation....Pages 89-94
Perfusion-Map Variations Demonstrate the Activity of the Retinal Autoregulation System in the Human Retina....Pages 95-101
The Primate Optic Nerve Following Chronic Ischemia....Pages 103-107
Multifocal Electroretinogram and Visual-Field Defects in Patients with Glaucoma....Pages 111-115
Association of Blue-on-Yellow Visual Field with Optic Disc and Retinal Nerve Fiber Layer....Pages 117-121
Comparison of Conventional and High-Pass Resolution Perimetry in a Prospective Study of Patients with Glaucoma and Normal Controls....Pages 123-123
Third Generation Rapid Algorithms for Static Computerised Perimetry, SITA. Development, Results and Observations....Pages 125-131
Frequency-Doubling Threshold Perimetry in Glaucoma, Glaucoma Suspect, and Normal Eyes....Pages 133-140
The Spatial Distribution and Severity of Visual Field Defects in Asians with Primary Open-Angle Glaucoma and Primary Angle-Closure Glaucoma....Pages 141-144
Parapapillary Atrophy in the Chronic Open-Angle Glaucomas....Pages 147-151
Can Pulsatile Ocular Blood Flow Be a Predictor of Future Visual Field Loss in Normal-Tension Glaucoma?....Pages 153-155
Changes in the Optic-Nerve Head over Time in Normal-Tension Glaucoma....Pages 157-161
Role of Trabeculectomy and Calcium-Channel Blockers in the Treatment of Normal-Tension Glaucoma....Pages 163-166
Medical Therapy in Primary Angle-Closure Glaucoma: a Model for Evaluation of Its Efficacy....Pages 169-172
Quantitative Ultrasound Biomicroscopy....Pages 173-180
Occurrence of Cystoid Macular Edema in Eyes Treated with Latanoprost: Preliminary Analysis....Pages 183-189
Cytoskeletal and Cell-Junctional Modulation of Aqueous Outflow....Pages 191-195
Prostaglandin Effects on the Uveoscleral-Outflow Pathway....Pages 197-202
A Comparison of the Ocular Hypotensive Efficacy, Safety and Acceptability of Brimonidine 0.2% Twice Daily Versus Pilocarpine 2.0% Thrice Daily as Adjunct Therapy with Beta-Blockers....Pages 203-208
Classification of Developing Filtering Blebs after Trabeculectomy....Pages 211-216
Effects of Irrigation on Mitomycin-C Concentration and Pharmacokinetics Parameters in Rabbit’s Eyes....Pages 219-221
Investigation of the Lectin from the Edible Mushroom Agaricus bisporus as an Inhibitory Modulator of Healing after Trabeculectomy....Pages 223-227
Non-Penetrating Trabeculectomy with Aspiration of the Inner Wall of Schlemm’s Canal and Juxtacanalicular Trabeculum....Pages 229-234
Non-Penetrating Deep Sclerectomy with Collagen Device Versus Trabeculectomy....Pages 235-239
A Retrospective Analysis of the Incidence of Endophthalmitis in Eyes with Chronic Bleb Leaks....Pages 243-247
Retinectomy Lowers Intraocular Pressure in Otherwise Intractable Glaucoma. Long-Term Follow-Up....Pages 249-252
5-Methylurapidil, 8-Iso Prostaglandin E 2 : New Drugs to Increase Aqueous-Humor Outflow Facility....Pages 253-259
Aqueous Shunting Procedures Versus Trabeculectomy with Antimetabolites for Surgical Control of Glaucoma: An (International?) Clinical Trial....Pages 261-264
Can Our Patients Afford Our Skepticism?....Pages 265-267